Subscribe
MENU
Home
BPCIA Litigations
PTAB Tracker
FDA Approvals
Editors
Publications
Big Molecule Watch
BREAKING NEWS: D. Ct. Rules BPCIA 180-day Notice is Mandatory for Apotex’s pegfilgrastim product, Grants Preliminary Injunction in
Amgen v. Apotex
The order can be found
here
. Analysis to follow shortly.
Comments are closed.